Navigation Links
Halozyme to Host Third Quarter Financial Results Conference Call
Date:11/1/2012

SAN DIEGO, Nov. 1, 2012 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the third quarter 2012 on Thursday, November 8, 2012 at 4:30 p.m. ET/1:30 p.m. PT. Gregory I. Frost, President and Chief Executive Officer, will lead the call. On the same date post-market, Halozyme will release financial results for the third quarter 2012.

(Logo: http://photos.prnewswire.com/prnh/20100302/LA63139LOGO)

The call will be webcast live through the "Investors" section of Halozyme's corporate website and a recording will be made available following the close of the call. To access the webcast, please log on to www.halozyme.com approximately fifteen minutes prior to the call to register, download and install any necessary audio software. For those without access to the Internet, the live call may be accessed by phone by calling (877) 407-8037 (domestic callers) or (201) 689-8037 (international callers). A telephone replay will be available shortly after the call by dialing (877) 660-6853 (domestic callers) or (201) 612-7415 (international callers) using replay ID number 402796.

About Halozyme

Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. With a diversified portfolio of enzymes that target the extracellular matrix, the Company's research focuses primarily on a family of human enzymes, known as hyaluronidases, that increase the absorption and dispersion of biologics. Halozyme's pipeline addresses therapeutic areas, such as diabetes, oncology and dermatology that have significant unmet medical need. The Company markets HYLENEX® recombinant (hyaluronidase human injection) and has partnerships with Roche, Ba
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Halozyme Reports Second Quarter 2012 Financial Results
2. Halozyme Confirms Baxter Has Received A Complete Response Letter For HyQ BLA
3. Halozymes Ultrafast Insulin Formulations Improved Postprandial Glycemic Control in Patients Living with Type 1 Diabetes: Phase 2 Study Results Presented at ADA 2012
4. Halozyme Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
5. Halozyme Reports First Quarter 2012 Financial Results
6. Halozyme to Host First Quarter 2012 Financial Results Conference Call
7. BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2012 Financial Results on November 8, 2012
8. PDL BioPharma to Announce Third Quarter 2012 Financial Results on November 5, 2012
9. Cumberland Pharmaceuticals Reports Third Quarter 2012 Financial Results
10. HeartWare Schedules Third Quarter Conference Call And Webcast
11. AcelRx Pharmaceuticals to Hold Third Quarter 2012 Financial Results Conference Call and Webcast on November 6, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... CHAPEL HILL, N.C. , Dec. 19, 2014 ... how to optimize a product,s web presence to ... critical. Brand websites, in particular, must meet the ... in regulations and culture. According ... LLC, more than half of the participating companies ...
(Date:12/19/2014)... 18, 2014 Somewhere between dropping five pounds ... forgotten. But Audicus , a next-generation hearing aids ... new year. Hearing loss is the third ... though it is often unaddressed. Forty-eight million Americans have ... hearing aid, mainly due to price. Hearing aids traditionally ...
(Date:12/19/2014)... -- RESMED INC. (NYSE: RMD ) today announced that ... results on Thursday, January 22, 2015, after the New York ... will be issued after 1:00 p.m. US Pacific Time and ... and future outlook. The earnings call is scheduled ... live webcast of the call can be accessed on ResMed,s ...
Breaking Medicine Technology:Building a Best-in-Class Pharma Global Brand Website 2Audicus Will Help People Resolve to Hear Better in 2015 2ResMed To Announce Second Quarter 2015 Results 2
... Continued Safety, Consistently Positive Clinical ... Results ... today from,Abbott,s SPIRIT III U.S. pivotal clinical trial demonstrated continued,positive, ... Stent System at one year, including continued,clinical superiority in major ...
... WASHINGTON, Oct. 22 The preliminary results ... OrbusNeich,s pro-healing stent, the,Genous Bio-engineered R stent, ... risk of restenosis patients show comparable efficacy ... de Winter, M.D., Ph.D.,principal investigator and director ...
Cached Medicine Technology:Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial 2Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial 3Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial 4Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial 5Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) and Boston Scientific's Taxus(R) Stent in Patients at High Risk of Restenosis 2
(Date:12/21/2014)... 22, 2014 In this report, ... by power source, product, and application. The market, ... and pneumatic instruments. By product, the market covers ... segments. The handpieces market is further subdivided into ... coagulators, laparoscopic instruments, shavers, wire/pin drivers, and others. ...
(Date:12/21/2014)... Khanna Vision Institute is pleased to ... Aspen Helicopters holiday event for underprivileged kids. The highlight ... flown by an aspen helicopter pilot. In the cover ... sleigh was visible.(please see accompanying video). Helicopter pilots require ... helped many pilots with Pi in eye vision correction. ...
(Date:12/21/2014)... Dennis Thompson HealthDay Reporter ... tobacco smokers find e-cigarettes less addictive than traditional cigarettes, new ... often as they did regular cigarettes, thousands of ex-smokers said ... impulsive and irritable over their need to smoke, researchers reported. ... score was significantly less for e-cig use than for tobacco ...
(Date:12/21/2014)... Francisco, California (PRWEB) December 21, 2014 ... his search for Vintage 1967 Jm Morrison and the Doors ... concert posters. This would also be the only time ... The concert was on Nov. 25, 1967. According to ... Washington D.C. They did play the Alexandria Roller Rink ...
(Date:12/21/2014)... Aliso Viejo, California (PRWEB) December 21, 2014 ... Film Studios have announced a new intro plugin for ... users to animate pictures, videos, logos, and more with ... Studios. “We’ve given our users the tools needed to ... Studios' ProMotion allows Final Cut Pro X users to ...
Breaking Medicine News(10 mins):Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 3Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 4Health News:E-Cigarettes Less Addictive Than Regular Cigarettes, Study Finds 2Health News:E-Cigarettes Less Addictive Than Regular Cigarettes, Study Finds 3Health News:Announcing a new plugin for Final Cut Pro X ProMotion from Pixel Film Studios. 2
... The number of cases of a new form of deadly ... and Canada, The SARS virus was first detected in South ... per reports from the World Health Organization the follwing cases ... up-to-date details as of May 23:// , ,Total number of ...
... to review the epidemiologic data on SARS.,Existing public ... disease in many countries and ,should be worked ... is now concentrated.,Crucial measures are taken to control ... like,detection and treatment of suspected cases as soon//,as ...
... a gene that might be responsible for asthma. Scientists ... the disease, hence leading to better,treatments. There are about ... person's susceptibility,to asthma. With combined efforts internationally, doctors have ... PHF11, was found on chromosome 13, a chromosome that ...
... A recent research findings indicates that treatments for both ... disorders. A study was conducted on people with migraine ... their psychiatric comorbidity was assessed, researchers found that the ... was three times higher than in individuals with no ...
... found that radiotherapy helps in natural tumor control process. ... When experiments were conducted on mice researchers identified an ... This enzyme destroys tumor nourishing blood vessels to die. ... it was thought that damage to the DNA in ...
... indicates teenagers are getting fatter not because they are ... when analysed data on diet, weight, and physical activity ... 10%, calorie intake rose 1%, while physical activity dropped ... active, they doesn't completely agree teens have not been ...
Cached Medicine News:Health News:Scientists review SARS 2
4 Gently Curved, Prongs, 5mm Extended, Stainless Steel Tip; with Titanium Handle....
12mm from bend to 0.12mm 1x2 teeth; In Titanium....
Straight Shafts with 0.2mm 1X2 Teeth, 5mm Tying Platform; In Titanium....
Curved Shaft with 5mm Platform; 1x2, 0.12 mm teeth; In Titanium....
Medicine Products: